Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Gierach GL.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju425. doi: 10.1093/jnci/dju425. Print 2015 Mar.

PMID:
25663687
2.

Using natural language processing to extract mammographic findings.

Gao H, Aiello Bowles EJ, Carrell D, Buist DS.

J Biomed Inform. 2015 Apr;54:77-84. doi: 10.1016/j.jbi.2015.01.010. Epub 2015 Feb 3.

PMID:
25661260
3.

Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer.

Onitilo AA, Onesti JK, Single RM, Engel JM, James TA, Aiello Bowles EJ, Spencer Feigelson H, Barney T, McCahill LE.

PLoS One. 2013 Dec 20;8(12):e84535. doi: 10.1371/journal.pone.0084535. eCollection 2013.

4.

Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system.

Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH.

J Cancer Surviv. 2014 Jun;8(2):229-38. doi: 10.1007/s11764-013-0335-1. Epub 2013 Dec 19.

PMID:
24352871
5.

Nurse navigators in early cancer care: a randomized, controlled trial.

Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R.

J Clin Oncol. 2014 Jan 1;32(1):12-8. doi: 10.1200/JCO.2013.51.7359. Epub 2013 Nov 25.

6.

Reply: To PMID 23490543.

Onitilo AA, Engel JM, James TA, Aiello Bowles EJ, McCahill LE, Feigelson HS.

J Am Coll Surg. 2013 Nov;217(5):960-2. doi: 10.1016/j.jamcollsurg.2013.07.396. No abstract available.

PMID:
24139222
7.

Circulating serum xenoestrogens and mammographic breast density.

Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Aiello Bowles EJ, Sisney GS, Burnside ES.

Breast Cancer Res. 2013 May 27;15(3):R45. doi: 10.1186/bcr3432.

8.

Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS.

J Oncol Pract. 2012 Nov;8(6):e149-57. doi: 10.1200/JOP.2012.000543. Epub 2012 Jul 17.

9.

Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study.

Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, Bakerman JE, McCahill LE.

J Am Coll Surg. 2013 May;216(5):966-75. doi: 10.1016/j.jamcollsurg.2013.01.011. Epub 2013 Mar 13.

10.

Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.

Ritzwoller DP, Carroll NM, Delate T, Hornbrook MC, Kushi L, Aiello Bowles EJ, Freml JM, Huang K, Loggers ET.

Lung Cancer. 2012 Dec;78(3):245-52. doi: 10.1016/j.lungcan.2012.09.008. Epub 2012 Sep 27.

11.

Mammographic breast density and serum phytoestrogen levels.

Lowry SJ, Sprague BL, Aiello Bowles EJ, Hedman CJ, Hemming J, Hampton JM, Burnside ES, Sisney GA, Buist DS, Trentham-Dietz A.

Nutr Cancer. 2012 Aug;64(6):783-9. doi: 10.1080/01635581.2012.707279. Epub 2012 Aug 3.

12.

Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer.

Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ; Pharmacovigilance Research Group.

Med Care. 2014 May;52(5):e30-8. doi: 10.1097/MLR.0b013e31825a8c22.

PMID:
22643199
13.

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

Ritzwoller DP, Carroll N, Delate T, O'Keeffe-Rossetti M, Fishman PA, Loggers ET, Aiello Bowles EJ, Elston-Lafata J, Hornbrook MC.

Med Care. 2013 Oct;51(10):e67-73. doi: 10.1097/MLR.0b013e31824def85.

14.

Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database.

Aiello Bowles EJ, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K, Engel J, Gundersen G, Sheehey-Jones J, Single R, Onitilo A, James TA, McCahill LE.

BMC Cancer. 2012 Apr 3;12:136. doi: 10.1186/1471-2407-12-136.

15.

Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

Delate T, Witt DM, Ritzwoller D, Weeks JC, Kushi L, Hornbrook MC, Aiello Bowles EJ, Schrag D.

Oncologist. 2012;17(3):419-27. doi: 10.1634/theoncologist.2011-0323. Epub 2012 Feb 14.

16.

Variability in reexcision following breast conservation surgery.

McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, Onitilo AA.

JAMA. 2012 Feb 1;307(5):467-75. doi: 10.1001/jama.2012.43.

PMID:
22298678
17.

The vitamin D pathway and mammographic breast density among postmenopausal women.

Sprague BL, Trentham-Dietz A, Gangnon RE, Buist DS, Burnside ES, Aiello Bowles EJ, Stanczyk FZ, Sisney GS, Skinner HG.

Breast Cancer Res Treat. 2012 Jan;131(1):255-65. doi: 10.1007/s10549-011-1726-5. Epub 2011 Aug 17.

18.

Predictors of breast density change after hormone therapy cessation: results from a randomized trial.

Lowry SJ, Aiello Bowles EJ, Anderson ML, Buist DS.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2309-12. doi: 10.1158/1055-9965.EPI-11-0629. Epub 2011 Aug 3.

19.

Improving modern cancer care through information technology.

Clauser SB, Wagner EH, Aiello Bowles EJ, Tuzzio L, Greene SM.

Am J Prev Med. 2011 May;40(5 Suppl 2):S198-207. doi: 10.1016/j.amepre.2011.01.014. Review.

20.

Timing of follow-up after abnormal screening and diagnostic mammograms.

Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS.

Am J Manag Care. 2011 Feb;17(2):162-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk